(Q53483475)

14 May 2018

title

Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. (English)

1 reference

14 May 2018

juvenile myoclonic epilepsy

1 reference

1 reference

Paul M Levisohn

1

1 reference

14 May 2018

Katherine D Holland

series ordinal

2

1 reference

14 May 2018

publication date

4 May 2007

1 reference

14 May 2018

published in

Epilepsy Behavior

1 reference

14 May 2018

volume

10

1 reference

14 May 2018

issue

4

1 reference

14 May 2018

page(s)

547-552

1 reference

14 May 2018

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Ion channels and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Topiramate in patients with juvenile myoclonic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

A method of quantification for the evaluation of antiepileptic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Seizures of idiopathic generalized epilepsies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Antiepileptic drugs as a cause of worsening seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Aggravation of epilepsy by antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2007.03.003

10.1016/J.YEBEH.2007.03.003

7 January 2021

Identifiers

DOI

1 reference

14 May 2018

release_mjssw7rmybewjoitmze2pfj3aq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mjssw7rmybewjoitmze2pfj3aq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 May 2018